Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1 Currently, there are an estimated 30 million people on antiretroviral treatment for HIV globally, of whom approximately 70% reside in Africa.2 Despite advancements in the provision of antiretroviral therapy […]

Alba Grifoni, HIVR4P 2021: T Cell Responses of SARS-CoV-2 Epitopes

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 23rd 2021

We were delighted to have the opportunity to speak with Dr Alba Grifoni ( La Jolla Institute for Immunology, La Jolla, CA, USA) to discuss T Cell responses of SARS-CoV-2 epitopes in COVID-19 cases.

Her abstract entitled: ‘B & T cell interactions: New studies on COVID-19’ (SY08.05) was presented at the HIVR4P Virtual Conference 2021, 04 February 2021.

Questions:

  1. What is already known about SARS-CoV-2-specific T cell responses and their impact on disease severity? (0:18)
  2. Could you give us a brief overview of the aims and design of your study? (1:48)
  3. How will the study data be used to enhance our understanding of immune responses to SARS-CoV-2 infection? (5:10)
  4. What gaps remain in our knowledge and what future studies are planned? (6:36)

Disclosures: Alba Grifoni has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Filmed in coverage of the HIVR4P 2021 Virtual Meeting.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup